LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Receivables
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Receivables of $4.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for the quarter ending 2026-06-30 was $10.86M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for the quarter ending 2026-03-31 was -$6.77M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for the quarter ending 2025-09-30 was $4.58M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for the quarter ending 2025-05-25 was $1.66M, a 200.72% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for fiscal 2025 was $2.26M, a 30.68% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for fiscal 2024 was $3.26M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for fiscal 2023 was -$10.82M, a 276.34% decline from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in receivables for fiscal 2022 was $6.14M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 3 month as first filed | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 7 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month | Increase (Decrease) in Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.08M 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | -$6.77M 10-Q · filed 2026-05-06 | ||||||||
| 2025-12-31 | -$2.29M 10-KT · filed 2026-03-16 | ||||||||
| 2025-09-30 | $4.58M 10-Q · filed 2025-11-06 | ||||||||
| 2025-05-25 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.89M 10-Q · filed 2026-08-05 | $2.26M 10-KT · filed 2026-03-16 | ||||||
| 2025-02-23 | $3.23M 10-Q · filed 2026-05-06 | $602.00K 10-Q · filed 2025-04-03 | |||||||
| 2024-08-25 | -$6.08M 10-Q · filed 2025-11-06 | -$5.52M derived: sum of 2 quarters · filed 2026-03-16 | |||||||
| 2024-05-26 | $552.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | $3.26M 10-KT · filed 2026-03-16 | |||||||
| 2024-02-25 | $2.71M 10-Q · filed 2025-04-03 | ||||||||
| 2023-05-28 | -$1.88M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $1.66M derived: sum of 2 quarters · filed 2024-03-20 | -$3.59M derived: sum of 3 quarters · filed 2024-03-20 | -$10.82M 10-K · filed 2024-03-20 | |||||
| 2023-02-26 | $3.54M derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | -$1.71M derived: sum of 2 quarters · filed 2024-03-20 | -$8.94M 10-K · filed 2024-03-20 | -$8.99M 10-Q · filed 2023-06-02 | -$10.33M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2022-11-27 | -$5.25M derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | -$12.48M 10-K · filed 2024-03-20 | -$13.87M derived: sum of 3 quarters · filed 2024-03-20 | -$1.80M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2022-08-28 | -$7.24M 10-K · filed 2024-03-20 | -$8.63M derived: sum of 2 quarters · filed 2024-03-20 | $3.44M derived: sum of 3 quarters · filed 2024-03-20 | $6.90M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2022-05-29 | -$1.39M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $10.68M derived: sum of 2 quarters · filed 2024-03-20 | $14.13M derived: sum of 3 quarters · filed 2024-03-20 | $6.14M 10-K · filed 2024-03-20 | |||||
| 2022-02-27 | $12.07M derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | $15.52M derived: sum of 2 quarters · filed 2024-03-20 | $7.53M 10-K · filed 2024-03-20 | $8.10M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2021-11-28 | $3.46M derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | -$4.54M 10-K · filed 2024-03-20 | -$3.97M derived: sum of 3 quarters · filed 2024-03-20 | -$757.00K derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2021-08-29 | -$8.00M 10-K · filed 2024-03-20 | -$7.43M derived: sum of 2 quarters · filed 2024-03-20 | -$4.21M derived: sum of 3 quarters · filed 2024-03-20 | -$2.59M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2021-05-30 | $570.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $3.78M derived: sum of 2 quarters · filed 2024-03-20 | $5.40M derived: sum of 3 quarters · filed 2024-03-20 | -$5.78M 10-K · filed 2024-03-20 | |||||
| 2021-02-28 | $3.21M derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | $4.83M derived: sum of 2 quarters · filed 2024-03-20 | -$6.34M 10-K · filed 2024-03-20 | -$6.18M 10-Q · filed 2021-04-08 | $39.00K derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-11-29 | $1.62M derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | -$9.56M 10-Q · filed 2022-01-07 | -$9.66M 10-Q · filed 2021-01-07 | -$3.17M derived: sum of 3 quarters · filed 2024-03-20 | -$3.60M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-08-30 | -$11.18M 10-K · filed 2024-03-20 | -$4.79M derived: sum of 2 quarters · filed 2024-03-20 | -$5.22M derived: sum of 3 quarters · filed 2024-03-20 | $3.34M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2020-05-31 | $6.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $5.96M derived: sum of 2 quarters · filed 2023-03-16 | $14.52M derived: sum of 3 quarters · filed 2023-03-16 | $6.36M 10-K/A · filed 2023-03-16 | $6.64M 10-K · filed 2020-08-14 | ||||
| 2020-02-23 | -$424.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $8.14M derived: sum of 2 quarters · filed 2021-04-08 | -$27.00K 10-Q · filed 2021-04-08 | $198.00K 10-Q · filed 2020-04-03 | $9.57M derived: sum of 4 quarters · filed 2021-07-29 | ||||
| 2019-11-24 | $8.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $397.00K 10-Q · filed 2021-01-07 | $9.99M derived: sum of 3 quarters · filed 2021-07-29 | $10.65M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-08-25 | -$8.16M 10-Q · filed 2020-10-07 | $1.43M derived: sum of 2 quarters · filed 2021-07-29 | $2.09M derived: sum of 3 quarters · filed 2021-07-29 | $6.85M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-05-26 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $10.26M derived: sum of 2 quarters · filed 2021-07-29 | $15.02M derived: sum of 3 quarters · filed 2021-07-29 | $9.28M 10-K · filed 2021-07-29 | $8.86M 10-K · filed 2019-08-01 | ||||
| 2019-02-24 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $5.42M derived: sum of 2 quarters · filed 2020-04-03 | -$315.00K 10-Q · filed 2020-04-03 | $3.64M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-11-25 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | -$975.00K 10-Q · filed 2020-01-02 | $2.98M derived: sum of 3 quarters · filed 2020-08-14 | -$2.94M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-08-26 | -$5.74M 10-Q · filed 2019-10-03 | -$1.78M derived: sum of 2 quarters · filed 2020-08-14 | -$7.70M derived: sum of 3 quarters · filed 2020-08-14 | $809.00K derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-05-27 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | -$1.96M derived: sum of 2 quarters · filed 2020-08-14 | $6.54M derived: sum of 3 quarters · filed 2020-08-14 | $7.31M 10-K · filed 2020-08-14 | |||||
| 2018-02-25 | -$5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | $2.59M derived: sum of 2 quarters · filed 2019-04-04 | $3.35M 10-Q · filed 2019-04-04 | $4.18M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-11-26 | $8.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $9.27M 10-Q · filed 2019-01-07 | $10.10M derived: sum of 3 quarters · filed 2019-08-01 | $6.01M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-08-27 | $768.00K 10-Q · filed 2018-10-05 | $1.59M derived: sum of 2 quarters · filed 2019-08-01 | -$2.50M derived: sum of 3 quarters · filed 2019-08-01 | $3.36M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-05-28 | $824.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$3.27M derived: sum of 2 quarters · filed 2019-08-01 | $2.59M derived: sum of 3 quarters · filed 2019-08-01 | $336.00K 10-K · filed 2019-08-01 | |||||
| 2017-02-26 | -$4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | $1.77M derived: sum of 2 quarters · filed 2018-04-05 | -$488.00K 10-Q · filed 2018-04-05 | $2.99M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2016-11-27 | $5.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $3.60M 10-Q · filed 2018-01-05 | $7.08M derived: sum of 3 quarters · filed 2018-08-09 | -$274.00K derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2016-08-28 | -$2.26M 10-Q · filed 2017-09-28 | $1.23M derived: sum of 2 quarters · filed 2018-08-09 | -$6.13M derived: sum of 3 quarters · filed 2018-08-09 | -$370.00K derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2016-05-29 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | -$3.88M derived: sum of 2 quarters · filed 2018-08-09 | $1.89M derived: sum of 3 quarters · filed 2018-08-09 | -$73.00K 10-K · filed 2018-08-09 | |||||
| 2016-02-28 | -$7.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | -$1.60M derived: sum of 2 quarters · filed 2017-04-07 | -$3.56M 10-Q · filed 2017-04-07 | -$2.65M derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2015-11-29 | $5.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | $3.80M 10-Q · filed 2017-01-05 | $4.70M derived: sum of 3 quarters · filed 2018-03-15 | -$2.28M derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2015-08-30 | -$1.96M 10-Q · filed 2016-09-29 | -$1.06M derived: sum of 2 quarters · filed 2018-03-15 | -$8.05M derived: sum of 3 quarters · filed 2018-03-15 | $455.00K derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2015-05-31 | $900.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | -$6.09M derived: sum of 2 quarters · filed 2018-03-15 | $2.41M derived: sum of 3 quarters · filed 2018-03-15 | $1.75M 10-K/A · filed 2018-03-15 | $1.75M 10-K · filed 2015-07-31 | ||||
| 2015-03-01 | -$6.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $1.51M derived: sum of 2 quarters · filed 2016-03-30 | $585.00K 10-Q · filed 2016-03-30 | $3.56M derived: sum of 4 quarters · filed 2016-08-01 | |||||
| 2014-11-30 | $8.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $7.57M 10-Q · filed 2016-01-07 | $10.55M derived: sum of 3 quarters · filed 2016-08-01 | $9.85M derived: sum of 4 quarters · filed 2016-08-01 | |||||
| 2014-08-31 | -$929.00K 10-Q · filed 2015-10-01 | $2.05M derived: sum of 2 quarters · filed 2016-08-01 | $1.35M derived: sum of 3 quarters · filed 2016-08-01 | $10.12M derived: sum of 4 quarters · filed 2016-08-01 | |||||
| 2014-05-25 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $2.31M derived: sum of 2 quarters · filed 2016-08-01 | $11.08M derived: sum of 3 quarters · filed 2016-08-01 | $7.98M 10-K · filed 2016-08-01 | $7.99M 10-K · filed 2014-08-01 | ||||
| 2014-02-23 | -$704.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $8.07M derived: sum of 2 quarters · filed 2015-04-02 | $4.97M 10-Q · filed 2015-04-02 | $3.77M derived: sum of 4 quarters · filed 2015-07-31 | |||||
| 2013-11-24 | $8.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $5.67M 10-Q · filed 2015-01-09 | $4.48M derived: sum of 3 quarters · filed 2015-07-31 | $1.15M derived: sum of 4 quarters · filed 2015-07-31 | |||||
| 2013-08-25 | -$3.10M 10-Q · filed 2014-10-08 | -$4.29M derived: sum of 2 quarters · filed 2015-07-31 | -$7.62M derived: sum of 3 quarters · filed 2015-07-31 | $2.68M derived: sum of 4 quarters · filed 2015-07-31 | |||||
| 2013-05-26 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$4.52M derived: sum of 2 quarters · filed 2015-07-31 | $5.78M derived: sum of 3 quarters · filed 2015-07-31 | $4.12M 10-K · filed 2015-07-31 | |||||
| 2013-02-24 | -$3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $6.97M derived: sum of 2 quarters · filed 2014-03-28 | $5.32M 10-Q · filed 2014-03-28 | $6.84M derived: sum of 4 quarters · filed 2014-08-01 | |||||
| 2012-11-25 | $10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $8.64M 10-Q · filed 2014-01-03 | $10.17M derived: sum of 3 quarters · filed 2014-08-01 | $4.48M derived: sum of 4 quarters · filed 2014-08-01 | |||||
| 2012-08-26 | -$1.66M 10-Q · filed 2013-09-26 | $1.66M 10-Q · filed 2012-10-03 | -$128.00K derived: sum of 2 quarters · filed 2014-08-01 | -$5.82M derived: sum of 3 quarters · filed 2014-08-01 | $2.88M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-05-27 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | -$4.16M derived: sum of 2 quarters · filed 2014-08-01 | $4.54M derived: sum of 3 quarters · filed 2014-08-01 | $3.25M 10-K · filed 2014-08-01 | |||||
| 2012-02-26 | -$5.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $3.01M derived: sum of 2 quarters · filed 2013-04-04 | $1.72M 10-Q · filed 2013-04-04 | -$1.72M 10-Q · filed 2012-03-28 | $5.40M derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-11-27 | $8.70M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $7.41M 10-Q · filed 2013-01-04 | -$7.41M 10-Q · filed 2012-01-05 | $11.09M derived: sum of 3 quarters · filed 2013-08-07 | |||||
| 2011-08-28 | -$1.29M 10-Q/A · filed 2013-01-02 | $1.29M 10-Q · filed 2011-10-05 | $2.39M derived: sum of 2 quarters · filed 2013-08-07 | ||||||
| 2011-05-29 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $3.02M 10-K · filed 2013-08-07 | |||||||
| 2011-02-27 | -$667.00K 10-Q · filed 2012-03-28 | ||||||||
| 2010-11-28 | -$6.03M 10-Q · filed 2012-01-05 | ||||||||
| 2010-08-29 | -$982.00K 10-Q · filed 2011-10-05 | ||||||||
| 2010-05-30 | $1.51M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |